Posted on October 29, 2019 by TMS Australia

Just recently the Medical Services Advisory Committee (MSAC) responsible for advising Medicare reimbursements is recommending public funding of TMS therapy for the treatment of depression in Australia.

Medicare funding is expected to come into effect late 2020 or early 2021, and many specifics need to be agreed upon. Until then, TMS treatment costs is $180 per session for private patients, and the number of sessions needed varies with the protocol and condition being treated.

Sign up to our newsletter (located at the bottom of our homepage) for more updates on this and much more.

Professor Paul Fitzgerald

“TMS being recommended a Medicare item number is a great endorsement of the treatment. There is still work to go until implementation, but this will open this treatment to many more patients!”

 

What does this mean for patients wanting TMS treatment?

This development means that more Australians will have access to Transcranial Magnetic Stimulation at little or no out-of-pocket costs through Medicare, with or without private health insurance.

Professor Paul Fitzgerald who co-founded the TMS Australia clinics shares his enthusiasm “TMS being recommended a Medicare item number is a great endorsement of the treatment. There is still work to go until implementation, but this will open this treatment to many more patients!”

“Some patients unnecessarily have to go into hospital to receive TMS treatment. This is all about to change!”, Dr Cassidy co-founder and Chief Medical Officer says. “If you have tried 2 antidepressants and don’t get better, TMS is statistically more likely to help than another medication.”

 

What happens between now and the expected Medicare funding of late 2020 or early 2021?

Until then, TMS treatment costs is $180 per session for private patients, and the number of sessions needed varies with the protocol and condition being treated.

TMS Australia will continue to offers outpatient TMS treatment to workers compensation and veteran patients, with funding agreements also available with some health insurers. Private patients can benefit from payment plans or early access to their superannuation.

 

What is TMS therapy?

Transcranial Magnetic Stimulation (also called rTMS or TMS) is a non-invasive treatment that involves stimulating the brain with magnetic pulses. TMS is recommended on by the Royal Australia and New Zealand College of Psychiatrists as a 2nd line treatment for major depression.